I think given we are doing trials on patients with advanced pancreatic cancer (I.e., metastatic or spreaded to lymph etc…) the company will get an indication if the drug works on cancer cells spreaded to other organs such as liver…
let’s see what the trial brings
Ann: Completion of Recruitment of ACCENT Trial, page-35
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.015(7.32%) |
Mkt cap ! $73.71M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 22.5¢ | 18.0¢ | $1.619M | 7.915M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 126222 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 110879 | 4 |
View Market Depth
| Last trade - 12.44pm 23/06/2025 (20 minute delay) ? |
| ATX (ASX) Chart |